Iron Deficiency in Women: Causes, Symptoms, Drugs That Cause It, and How to Treat It

Why Women Lose More Iron Than Men

Women of reproductive age lose iron every month through menstruation, and that loss compounds across pregnancy, postpartum recovery, and breastfeeding. Men rarely develop iron deficiency unless they have a gastrointestinal bleed or a malabsorptive condition. For women, the causes are layered and life-stage specific.

The World Health Organization estimates that iron deficiency anemia affects roughly 30% of women globally, making it the single most common micronutrient deficiency on the planet. But anemia, the final stage of depletion, is only the tip of the problem. Ferritin can drop well before hemoglobin falls, producing symptoms that are real and disabling even when a standard CBC looks "normal."

The Iron Physiology That's Unique to Female Bodies

Women absorb iron through the duodenum, regulated by hepcidin, a liver-produced hormone that acts as the body's iron gatekeeper. Estrogen downregulates hepcidin, which means women in their reproductive years have a slight absorption advantage. That advantage disappears after menopause, when estrogen falls and hepcidin rises. Research published in the journal Blood has confirmed this estrogen-hepcidin relationship, explaining in part why postmenopausal women do not share the same deficiency pattern as younger women.

During the luteal phase of your menstrual cycle, inflammatory cytokines rise modestly, which can also transiently raise hepcidin and blunt iron absorption in the days before your period. This is not a clinically large effect, but it adds to the monthly loss story.

Life Stage Breakdown

Reproductive years (ages 12 to 51, approximately). Monthly menstrual loss averages 30 to 40 mL of blood per cycle. Women with menorrhagia (bleeding exceeding 80 mL per cycle) lose two to three times that. A single heavy period can cost 30 to 40 mg of elemental iron, which is more than most women replace through diet in one day. ACOG defines heavy menstrual bleeding as soaking through a pad or tampon every hour for several consecutive hours.

Trying to conceive and early pregnancy. Iron stores before conception directly affect embryo implantation quality and early fetal neural development. The American Journal of Obstetrics and Gynecology notes that maternal iron deficiency in the first trimester is associated with increased risk of preterm birth and low birth weight. Getting ferritin above 30 ng/mL before conceiving is a reasonable preconception target.

Pregnancy. Blood volume expands by approximately 45% during pregnancy. The National Institutes of Health recommends 27 mg of iron per day during pregnancy, compared with 18 mg for non-pregnant women of reproductive age. The fetal demand peaks in the third trimester, and women entering pregnancy with low ferritin rarely catch up on diet alone.

Postpartum and lactation. Birth involves blood loss averaging 300 to 500 mL for a vaginal delivery and 750 to 1,000 mL for a cesarean section. Ferritin can plummet in the weeks after delivery. Breastfeeding does not cause significant additional iron loss (breast milk contains very little iron), but restoring stores after a depleting birth takes months without supplementation.

Perimenopause. Cycles often become heavier and more irregular in the four to eight years before the final menstrual period. Many women in their 40s incorrectly attribute fatigue, brain fog, and shortness of breath to "just perimenopause" when iron deficiency is driving or amplifying those symptoms. The Menopause Society (NAMS) recognizes sleep disruption and cognitive changes as features of perimenopause, but iron deficiency must be excluded as a contributor.

Postmenopause. After periods stop, iron deficiency should not be assumed to be dietary. The American Journal of Gastroenterology guidelines recommend GI evaluation for any postmenopausal woman with iron deficiency to rule out colorectal cancer, gastric cancer, or peptic ulcer disease before attributing the deficiency to any other cause.

Symptoms of Iron Deficiency: What Women Actually Feel

Symptoms range from subtle and easy to dismiss to genuinely disabling. The classic picture is fatigue, pallor, and shortness of breath, but that is the anemia presentation. Iron deficiency without anemia has its own set of symptoms that often get missed.

Early Stage: Depleted Stores, Normal Hemoglobin

• Fatigue that sleep does not fix
• Reduced exercise tolerance (your usual workout feels harder)
• Difficulty concentrating or word-finding problems
• Cold hands and feet, even in warm environments
• Restless leg syndrome, particularly at night
• Increased frequency of infections (iron supports immune function)

A 2021 study in the BMJ found that treating iron deficiency without anemia in women with fatigue improved self-reported energy scores significantly compared with placebo, confirming that the threshold for treatment should not wait for hemoglobin to drop.

Later Stage: Iron Deficiency Anemia

• Pale inner eyelids and pale nail beds
• Pounding or racing heartbeat (palpitations)
• Shortness of breath on mild exertion
• Brittle nails, spoon-shaped nails (koilonychia)
• Hair shedding (telogen effluvium driven by iron deficiency is a recognized phenomenon; a review in Skin Appendage Disorders confirmed ferritin below 30 ng/mL as a threshold for hair cycle disruption)
• Pica (craving ice, dirt, or starch), which is pathognomonic for severe iron deficiency

Symptoms Specific to PCOS

Women with PCOS face a double burden. Anovulatory cycles can produce irregular but extremely heavy breakthrough bleeds, and insulin resistance may affect ferritin metabolism independently. A study published in Fertility and Sterility found that iron status varied significantly by PCOS phenotype, with women who had heavy anovulatory bleeding showing the lowest ferritin levels.

Drugs That Cause Iron Deficiency

Several commonly prescribed medications either reduce iron absorption or contribute to blood loss, creating deficiency even in women whose diet and physiology would otherwise be sufficient.

Proton Pump Inhibitors (PPIs)

PPIs (omeprazole, pantoprazole, lansoprazole, esomeprazole, rabeprazole) suppress gastric acid production. Iron absorption from food requires an acidic stomach environment to convert ferric iron (Fe3+) to ferrous iron (Fe2+), the absorbable form. Long-term PPI use is associated with iron deficiency, and a large cohort study in Gut found a statistically significant association between PPI use longer than one year and incident iron deficiency anemia. Women on PPIs for GERD or gastric protection alongside NSAIDs are especially at risk.

NSAIDs and Aspirin

Non-steroidal anti-inflammatory drugs do not deplete iron directly, but they cause chronic subclinical GI bleeding in a significant proportion of users. The FDA label for ibuprofen acknowledges GI bleeding as a dose-dependent risk. Women who use NSAIDs regularly for endometriosis pain, menstrual cramps, or arthritis may be silently losing iron through the gut while also losing it through their periods.

Antacids (Calcium Carbonate, Magnesium Hydroxide)

Calcium competes directly with iron for absorption through the same intestinal transporter (DMT1). Taking calcium supplements or antacids within two hours of an iron supplement can reduce iron absorption by up to 50%, according to research summarized by the NIH Office of Dietary Supplements. This is practically important for women who take calcium for bone health and iron for deficiency at the same time.

Certain Antibiotics

Tetracyclines (doxycycline, minocycline) and fluoroquinolones (ciprofloxacin, levofloxacin) chelate iron in the gut, forming insoluble complexes that prevent absorption of both the iron and the antibiotic. Women on doxycycline for acne or SIBO should separate iron supplements by at least two hours. The NIH interaction guidance specifically flags this interaction.

Oral Contraceptives (Nuance Required)

Combination oral contraceptives (COCs) typically reduce menstrual blood loss by 40 to 50%, which is why they are sometimes prescribed specifically to manage iron deficiency from heavy periods. However, the progestin-only pill and the hormonal IUD (levonorgestrel-IUD) have variable effects on bleeding patterns. The copper IUD reliably increases menstrual blood loss by approximately 20 to 30%, according to ACOG Practice Bulletin 121, and women using it should have iron monitored periodically.

Cholestyramine and Other Bile Acid Sequestrants

Cholestyramine, prescribed for high LDL or bile acid diarrhea, binds to iron in the gut and reduces absorption. Women using this medication for cholestasis of pregnancy or postpartum hypercholesterolemia should be aware of the interaction.

How Iron Deficiency Is Diagnosed in Women

A standard complete blood count (CBC) alone will miss iron deficiency in its early stages. Hemoglobin does not fall until iron stores are nearly exhausted. Here is the proper diagnostic sequence:

First-Line Tests

1. Serum ferritin. The single most sensitive marker of depleted iron stores. A ferritin below 30 ng/mL indicates deficiency even with a normal hemoglobin. Some guidelines, including those from the British Society of Gastroenterology, use a threshold of <45 ng/mL in symptomatic patients.
2. CBC with differential. Microcytic, hypochromic red cells (low MCV, low MCH) appear once deficiency is moderate to severe. A low hemoglobin (<12 g/dL in women by WHO criteria) confirms anemia.
3. Serum iron and TIBC. Low serum iron with elevated total iron-binding capacity (TIBC) is the classic pattern of iron deficiency. Transferrin saturation below 20% is consistent with deficiency.

Confounders That Trip Up Diagnosis in Women

Ferritin is an acute-phase reactant. It rises with inflammation, infection, and autoimmune disease even when iron stores are depleted. A woman with rheumatoid arthritis, lupus, or active PCOS may have a falsely reassuring ferritin in the "normal" range while her true stores are low. Requesting a C-reactive protein (CRP) alongside ferritin helps interpret results in this context.

Treatment for Iron Deficiency in Women

Oral Iron Supplements

Oral ferrous salts (ferrous sulfate, ferrous gluconate, ferrous fumarate) are first-line for mild to moderate deficiency. NIH guidance recommends 150 to 200 mg of elemental iron per day in divided doses for treatment of deficiency.

Ferrous sulfate 325 mg contains 65 mg of elemental iron. Three times daily gives 195 mg elemental iron, which is appropriate for treating frank anemia. For women with depleted stores but normal hemoglobin, once daily (65 mg elemental) is often effective and better tolerated.

The alternate-day dosing strategy. A landmark 2017 study in Blood by Stoffel et al. Showed that taking oral iron every other day, rather than daily, significantly increased fractional iron absorption by allowing hepcidin levels to fall between doses. This is particularly useful for women who experience significant GI side effects on daily dosing. Specifically, fractional absorption was 40% higher on alternate-day dosing compared with consecutive-day dosing in the study population. Alternate-day dosing is now incorporated into many clinical practice frameworks for managing iron deficiency in women with GI intolerance, yet it remains underused in primary care.

Minimizing Side Effects

GI side effects (nausea, constipation, dark stools) are the main reason women stop oral iron. Strategies that help:

• Take iron with a small amount of food if nausea is severe, accepting a modest reduction in absorption
• Take with vitamin C (500 mg) to enhance absorption of ferrous salts
• Switch from ferrous sulfate to ferrous gluconate (35 mg elemental iron per 325 mg tablet), which is gentler on the gut
• Use alternate-day dosing as described above
• Avoid taking iron within two hours of coffee, tea, dairy, calcium supplements, PPIs, or antacids

IV Iron

Intravenous iron is indicated when oral iron fails, is not tolerated, or when the clinical situation demands rapid repletion (such as in the third trimester, postpartum hemorrhage recovery, or pre-surgical optimization). Available IV formulations in the U.S. Include ferric carboxymaltose (Injectafer), ferumoxytol (Feraheme), low-molecular-weight iron dextran (INFed), and ferric gluconate (Ferrlecit).

A 2019 Cochrane review of IV iron in pregnancy found that IV iron raised hemoglobin more rapidly than oral iron and was associated with higher ferritin at delivery, without significant difference in serious adverse events. Anaphylaxis risk with modern formulations (ferric carboxymaltose, ferumoxytol) is low but not zero; administration requires clinical monitoring for at least 30 minutes post-infusion.

Treating the Underlying Cause

Supplementing iron without addressing the source of loss is incomplete care.

• Heavy periods: Hormonal IUD (levonorgestrel 52 mg, Mirena) reduces menstrual blood loss by up to 90% and is a first-line option for managing menorrhagia-related iron deficiency according to ACOG Practice Bulletin 128. Combination oral contraceptives, tranexamic acid, and progestin-only pills are alternatives.
• PCOS: Addressing anovulation with combined hormonal contraception or cyclic progestins stabilizes bleeding patterns and iron loss.
• GI blood loss: Any postmenopausal woman with new iron deficiency needs colonoscopy and upper endoscopy, per ACG guidelines.
• Malabsorption: Celiac disease is three times more common in women than men and is a frequently overlooked cause of refractory iron deficiency. A tissue transglutaminase IgA (tTG-IgA) should be checked in women who fail oral iron therapy.

Pregnancy and Lactation: What You Need to Know

Pregnancy

Iron deficiency is the most common nutritional deficiency in pregnancy. ACOG Committee Opinion 824 recommends screening all pregnant women for iron deficiency anemia at the first prenatal visit. Women with hemoglobin below 11 g/dL in the first or third trimester, or below 10.5 g/dL in the second trimester, meet the WHO threshold for anemia in pregnancy.

Supplemental iron is considered safe throughout pregnancy. Prenatal vitamins typically contain 27 mg of elemental iron, which meets the RDA for pregnancy but may be insufficient to treat established deficiency. Women with documented deficiency need therapeutic doses (ferrous sulfate 325 mg once to three times daily, depending on severity) in addition to their prenatal vitamin.

IV iron in pregnancy is not contraindicated after the first trimester. Ferric carboxymaltose is the most studied formulation in pregnancy and is generally reserved for the second and third trimesters when oral iron is not adequate or tolerated.

Contraception note: Iron is not a teratogen. There are no contraception requirements specific to iron supplementation itself. However, if the cause of iron deficiency is being treated with medications that do carry teratogenic risk (such as certain antibiotics for H. Pylori eradication, or medications for underlying inflammatory bowel disease), those contraception requirements apply separately.

Lactation

Iron does not transfer meaningfully into breast milk; breast milk contains only about 0.2 to 0.4 mg/L of iron regardless of maternal iron status. Supplementing iron while breastfeeding does not appreciably change the iron content of your milk. The infant relies on their own stored iron (accumulated in the third trimester) for the first six months of life. For the breastfeeding mother, oral iron supplements are safe, and restoring maternal iron stores postpartum supports energy, mood, and cognitive recovery after birth.

Who This Is Right For and Who Should Be Cautious

Likely to benefit from iron evaluation and treatment

• Women with heavy periods (soaking more than one pad or tampon per hour for more than two consecutive hours)
• Women with PCOS and irregular or heavy anovulatory bleeding
• Pregnant women at any trimester, particularly those with prior deficiency
• Postpartum women, especially after cesarean delivery or hemorrhage
• Women using a copper IUD for more than one year
• Women on long-term PPIs for GERD
• Perimenopausal women with new fatigue, hair loss, or palpitations
• Women with known celiac disease, inflammatory bowel disease, or prior bariatric surgery

Needs caution or additional workup before supplementing

• Postmenopausal women: GI source must be ruled out first
• Women with hemochromatosis or a family history of hereditary hemochromatosis
• Women with chronic kidney disease (iron management is complex and often requires IV iron under nephrology guidance)
• Women with active infection or inflammatory conditions (treatment may need to be deferred or the approach modified)

The Evidence Gap: What We Do Not Know Yet

Women have been historically under-represented in iron physiology research. Most pharmacokinetic studies of oral iron formulations used mixed-sex populations without stratifying results by menstrual status, hormonal contraception use, or cycle phase. The hepcidin-estrogen relationship is based largely on animal models and small human studies. The optimal ferritin target for women with symptoms but normal hemoglobin is genuinely debated: some clinicians use 30 ng/mL, others use 50 ng/mL, and there is no large, randomized trial in women that has definitively established this threshold. A 2023 systematic review in the Annals of Internal Medicine acknowledged that evidence for treating iron deficiency without anemia is promising but based on heterogeneous trials with variable outcome measures. This is an area where clinical judgment and shared decision-making currently fill the evidence gap.